Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The present and future control of pertussis.

× No keyword cloud information.

28 in total

Review 1. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.

Authors: Shelly Bolotin; Eric T Harvill; Natasha S Crowcroft
Journal: Pathog Dis Date: 2015-08-06 Impact factor: 3.166

2. Bordetella pertussis naturally occurring isolates with altered lipooligosaccharide structure fail to fully mature human dendritic cells.

Authors: Jolanda Brummelman; Rosanne E Veerman; Hendrik Jan Hamstra; Anna J M Deuss; Tim J Schuijt; Arjen Sloots; Betsy Kuipers; Cécile A C M van Els; Peter van der Ley; Frits R Mooi; Wanda G H Han; Elena Pinelli
Journal: Infect Immun Date: 2014-10-27 Impact factor: 3.441

3. An outbreak of pertussis in rural Texas: an example of the resurgence of the disease in the United States.

Authors: Anthony O Eshofonie; Huai Lin; Randy P Valcin; LaTasha R Martin; Paul E Grunenwald
Journal: J Community Health Date: 2015-02

4. A novel TLR2 agonist from Bordetella pertussis is a potent adjuvant that promotes protective immunity with an acellular pertussis vaccine.

Authors: A Dunne; L A Mielke; A C Allen; C E Sutton; R Higgs; C C Cunningham; S C Higgins; K H G Mills
Journal: Mucosal Immunol Date: 2014-10-15 Impact factor: 7.313

5. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal: MMWR Recomm Rep Date: 2018-04-27

6. Understanding Trends in Pertussis Incidence: An Agent-Based Model Approach.

Authors: Erinn Sanstead; Cynthia Kenyon; Seth Rowley; Eva Enns; Claudia Miller; Kristen Ehresmann; Shalini Kulasingam
Journal: Am J Public Health Date: 2015-07-16 Impact factor: 9.308

7. Immunogenicity and safety after booster vaccination of diphtheria, tetanus, and acellular pertussis in young adults: an open randomized controlled trial in Japan.

Authors: Megumi Hara; Kenji Okada; Yuko Yamaguchi; Shingo Uno; Yasuko Otsuka; Chisato Shimanoe; Hinako Nanri; Mikako Horita; Iwata Ozaki; Yuichiro Nishida; Keitaro Tanaka
Journal: Clin Vaccine Immunol Date: 2013-10-09

8. The Bordetella pertussis type III secretion system tip complex protein Bsp22 is not a protective antigen and fails to elicit serum antibody responses during infection of humans and mice.

Authors: Rodrigo Villarino Romero; Ilona Bibova; Ondrej Cerny; Branislav Vecerek; Tomas Wald; Oldrich Benada; Jana Zavadilova; Radim Osicka; Peter Sebo
Journal: Infect Immun Date: 2013-05-20 Impact factor: 3.441

9. Seroprevalence of pertussis in Senegal: a prospective study.

Authors: Lobna Gaayeb; Jean Biram Sarr; Mamadou O Ndiath; Jean-Baptiste Hanon; Anne-Sophie Debrie; Modou Seck; Anne-Marie Schacht; Franck Remoué; Emmanuel Hermann; Gilles Riveau
Journal: PLoS One Date: 2012-10-31 Impact factor: 3.240

10. The stimulated innate resistance event in Bordetella pertussis infection is dependent on reactive oxygen species production.

Authors: E Zurita; G Moreno; A Errea; M Ormazabal; M Rumbo; D Hozbor
Journal: Infect Immun Date: 2013-04-29 Impact factor: 3.441